HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

Benzinga Newsdesk www.benzinga.com Positive 78.6%

Neg 0% Neu 0% Pos 78.6%

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy and raises the price target from $7 to $10.